T VOBIT 1MG 10

About

T VOBIT 1MG contains Voglibose, an alpha-glucosidase inhibitor used in the management of type 2 diabetes mellitus. Voglibose works by inhibiting the enzymes (alpha-glucosidases) located in the brush border of the small intestine that are responsible for breaking down complex carbohydrates into simpler sugars. By slowing down this enzymatic process, Voglibose delays the digestion and absorption of carbohydrates from the gastrointestinal tract. This action primarily helps to reduce the sharp rise in blood glucose levels that occurs after meals, known as post-prandial hyperglycemia.

Voglibose is particularly effective in controlling post-meal blood sugar spikes and can be used as monotherapy or in combination with other oral antidiabetic agents or insulin. It does not directly stimulate insulin secretion, thus carrying a lower risk of hypoglycemia when used alone. It is an important therapeutic option for patients whose primary challenge is elevated blood glucose levels after eating, contributing to overall better glycemic control.

Uses

• Management of type 2 diabetes mellitus.
• To reduce post-prandial hyperglycemia.
• Used as an adjunct to diet and exercise.
• May be used in combination with other antidiabetics.

Directions For Use

Take this medicine orally immediately before or with the first bite of each main meal, as directed by your physician.

Benefits

• Effectively reduces post-meal blood sugar spikes.
• Lowers overall blood glucose levels.
• Does not cause weight gain.
• Low risk of hypoglycemia (when used alone).
• Improves glycemic control.
• Can be combined with other therapies.

Side Effects

• Flatulence
• Abdominal discomfort
• Diarrhea
• Nausea
• Bloating
• Constipation
• Increased liver enzymes (rare)
• Hypoglycemia (when combined with sulfonylureas/insulin)
• Skin rash
• Headache
• Dizziness
• Vomiting

Safety Measures

• Alcohol - Moderate alcohol consumption is generally acceptable, but excessive intake should be avoided as it can affect blood sugar levels.
• Pregnancy - Not recommended during pregnancy due to insufficient safety data. Consult your doctor for alternative treatments.
• Breastfeeding - Not recommended during breastfeeding as it is unknown if Voglibose passes into breast milk. Seek medical advice.
• Liver - Use with caution in patients with severe liver impairment, as it may exacerbate existing conditions. Regular liver function monitoring may be advised.
• Kidney - Use with caution in patients with severe kidney impairment, as accumulation may occur. Dose adjustment or alternative therapy may be necessary.
• Lung - Generally safe for use in patients with lung conditions. No specific contraindications related to lung function.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.